好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Breakthroughs in Neurology Conference | SAT03 - Neurodegenerative Disease: Future Targets and Current Quality Measures

Saturday 01/14/17
08:00 AM - 11:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Janis M. Miyasaki, MD, MEd, FAAN
Participants will list new pathogenesis models for common neurodegenerative diseases.
Participants will be able to list potential new therapies in Parkinson's disease, MSA and Lewy Body Dementia.
Participants will be able to list some quality measures in Parkinson's disease to incorporate in their practice.
No CME available
Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement
Practitioner, Fellow, Academician, Resident, Nurse, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Audience Participation
Event Timeline
08:00 AM - 08:45 AM Quality Measures in Parkinson's Disease: Incorporating in your practice
Janis M. Miyasaki, MD, MEd, FAAN
08:45 AM - 09:30 AM New Molecular Targets in Neurodegnerative Diseases
Deborah Hall, MD, PhD, FAAN
09:30 AM - 09:45 AM Break
09:45 AM - 10:30 AM New Targets in Neurobehavioural Aspects of Movement Disorders
Jennifer G. Goldman, MD, MS, FAAN
10:30 AM - 11:00 AM Questions and Answers
Faculty Disclosures
Janis M. Miyasaki, MD, MEd, FAAN Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council.
Deborah Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Jennifer G. Goldman, MD, MS, FAAN Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.